These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 9260696
1. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. Navarro D, Lennette E, Tugizov S, Pereira L. J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696 [Abstract] [Full Text] [Related]
2. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pereira L. Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537 [Abstract] [Full Text] [Related]
3. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Tugizov S, Wang Y, Qadri I, Navarro D, Maidji E, Pereira L. Virology; 1995 Jun 01; 209(2):580-91. PubMed ID: 7778290 [Abstract] [Full Text] [Related]
4. Location, location, timing: analysis of cytomegalovirus epitopes for neutralizing antibodies. Schrader JW, McLean GR. Immunol Lett; 2007 Sep 15; 112(1):58-60. PubMed ID: 17714794 [Abstract] [Full Text] [Related]
5. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT, Bolin RA, Kelly RG. Virology; 1998 Jul 05; 246(2):317-28. PubMed ID: 9657950 [Abstract] [Full Text] [Related]
6. Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B. Britt WJ, Jarvis MA, Drummond DD, Mach M. J Virol; 2005 Apr 05; 79(7):4066-79. PubMed ID: 15767408 [Abstract] [Full Text] [Related]
7. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Virology; 1993 Nov 05; 197(1):143-58. PubMed ID: 7692667 [Abstract] [Full Text] [Related]
8. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy. Eggers M, Radsak K, Enders G, Reschke M. J Med Virol; 2001 Feb 05; 63(2):135-42. PubMed ID: 11170050 [Abstract] [Full Text] [Related]
9. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures. Schoppel K, Hassfurther E, Britt W, Ohlin M, Borrebaeck CA, Mach M. Virology; 1996 Feb 01; 216(1):133-45. PubMed ID: 8614980 [Abstract] [Full Text] [Related]
10. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection. Park JW, Kim DJ, Kim J, Park CG, Hwang ES, Cha CY. J Korean Med Sci; 2000 Apr 01; 15(2):133-8. PubMed ID: 10803687 [Abstract] [Full Text] [Related]
11. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Elkington R, Shoukry NH, Walker S, Crough T, Fazou C, Kaur A, Walker CM, Khanna R. Eur J Immunol; 2004 Nov 01; 34(11):3216-26. PubMed ID: 15368271 [Abstract] [Full Text] [Related]
12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA, Marlin SD, Schwartz SA, Glorioso JC. J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157 [Abstract] [Full Text] [Related]
13. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant. Muñoz I, Gutiérrez A, Gimeno C, Farga A, Alberola J, Solano C, Prósper F, García-Conde J, Navarro D. J Med Virol; 2001 Sep 01; 65(1):77-84. PubMed ID: 11505447 [Abstract] [Full Text] [Related]
14. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation. Gerna G, Percivalle E, Perez L, Lanzavecchia A, Lilleri D. J Virol; 2016 Jul 15; 90(14):6216-6223. PubMed ID: 27122579 [Abstract] [Full Text] [Related]
15. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Liu DX, Gompels UA, Foa-Tomasi L, Campadelli-Fiume G. Virology; 1993 Nov 15; 197(1):12-22. PubMed ID: 7692666 [Abstract] [Full Text] [Related]
16. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus. Wiegers AK, Sticht H, Winkler TH, Britt WJ, Mach M. J Virol; 2015 Jan 15; 89(1):361-72. PubMed ID: 25320309 [Abstract] [Full Text] [Related]
17. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo. Lilleri D, Kabanova A, Lanzavecchia A, Gerna G. J Clin Immunol; 2012 Dec 15; 32(6):1324-31. PubMed ID: 22836657 [Abstract] [Full Text] [Related]
18. Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties. Barrios Y, Knör S, Lantto J, Mach M, Ohlin M. Mol Immunol; 2007 Feb 15; 44(5):680-90. PubMed ID: 16824601 [Abstract] [Full Text] [Related]
19. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals. Ayata M, Sugano T, Murayama T, Sakamuro D, Takegami T, Matsumoto Y, Furukawa T. J Med Virol; 1994 Aug 15; 43(4):386-92. PubMed ID: 7525866 [Abstract] [Full Text] [Related]
20. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response. Urban M, Klein M, Britt WJ, Hassfurther E, Mach M. J Gen Virol; 1996 Jul 15; 77 ( Pt 7)():1537-47. PubMed ID: 8757997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]